Literature DB >> 28931780

Association between severity of obstructive sleep apnea and glycated hemoglobin level in Japanese individuals with and without diabetes.

Hideaki Kurosawa1, Yoshifumi Saisho1, Koichi Fukunaga2, Mizuha Haraguchi2, Wakako Yamasawa2, Isao Kurihara1, Tomoko Betsuyaku2, Hiroshi Itoh1.   

Abstract

Aim of this study was to examine the association between the severity of obstructive sleep apnea (OSA) and dysglycemia in Japanese individuals with and without type 2 diabetes (T2DM). We enrolled 115 individuals diagnosed with OSA with an apnea hypopnea-index (AHI) ≥ 20 in whom continuous positive airway pressure (CPAP) therapy was introduced (N = 115, 44 with T2DM, age 62 ± 11 years, BMI 27.0 ± 4.4 kg/m2 and AHI median 36.1; interquartile range 27.2-48.1). During admission, the severity of OSA was evaluated by polysomnography, and its association with glycated hemoglobin (HbA1c) level was examined. Continuous glucose monitoring (CGM) was also conducted during the admission in 94 individuals. Apnea-hypopnea index (AHI), non-rapid eye movement (REM) AHI, minimum peripheral capillary oxygen saturation (SpO2) and percentage of sleep time (%TST) with SpO2 < 90% were significantly associated with HbA1c level in total and non-diabetic individuals (all p < 0.05) but not in those with T2DM, the majority of whom were treated with anti-diabetic medications. The associations of the non-REM AHI and %TST with SpO2 < 90% with HbA1c level remained significant after adjustment for age, sex and BMI in non-diabetic and T2DM subjects treated with dietary therapy only. Mean glucose level, but not SD or coefficient of variation of glucose, assessed by CGM was significantly associated with AHI and non-REM AHI in non-diabetic subjects after adjustment for age, sex and BMI. In conclusion, the severity of OSA was associated with increased HbA1c level independently of BMI in Japanese individuals, especially in those without diabetes.

Entities:  

Keywords:  Apnea-hypopnea index; Continuous glucose monitoring; Obstructive sleep apnea; Oxygen saturation; Type 2 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28931780     DOI: 10.1507/endocrj.EJ17-0356

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Blood glucose dynamics during sleep in patients with obstructive sleep apnea and normal glucose tolerance: effects of CPAP therapy.

Authors:  Kimimasa Saito; Yosuke Okada; Keiichi Torimoto; Yoko Takamatsu; Yoshiya Tanaka
Journal:  Sleep Breath       Date:  2021-08-11       Impact factor: 2.655

2.  Association between sleep-disordered breathing and lower extremity artery disease: a meta-analysis.

Authors:  Yuhong Chen; Xiaocheng Li; Liming Zhao; Gang Wu
Journal:  Sleep Breath       Date:  2020-05-12       Impact factor: 2.816

Review 3.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

4.  Effects of CPAP on the transcriptional signatures in patients with obstructive sleep apnea via coexpression network analysis.

Authors:  Juxiang Peng; Jukun Song; Jing Zhou; Xinhai Yin; Jinlin Song
Journal:  J Cell Biochem       Date:  2019-02-05       Impact factor: 4.429

5.  Evaluation of obstructive sleep apnea in metabolic syndrome.

Authors:  Divya Soin; Praveen Ashok Kumar; Jasmeen Chahal; Sumit Pal Singh Chawla; Sarabjot Kaur; Ravinder Garg; Rupinderjeet Kaur
Journal:  J Family Med Prim Care       Date:  2019-05

6.  The relationship between coffee intake, obstructive sleep apnea risk, and type 2 diabetes glycemic control, in Tabuk City, The Kingdom of Saudi Arabia: a case-control study.

Authors:  Mohammed Adam Ahmed Elnour; Abdulmoneim Ahmed Saleh; Mowffaq Mohammed Kalantan; Hyder Osman Mirghani
Journal:  BMC Res Notes       Date:  2019-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.